Emin Sami Arısoy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Emin Sami Arısoy has a total of 141 co-authors. Here are the top co-authors by number of shared publications:
- Ateş Kara
Division of Pediatric Infectious Diseases, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Türkiye
7 shared publications - Ayper Somer
Istanbul University
6 shared publications - Hasan Tezer
Department of Pediatric Infectious Diseases, Faculty of Medicine, Gazi University, Ankara, Turkey
6 shared publications - Mustafa Hacımustafaoğlu
Department of Pediatric Infectious Diseases, Faculty of Medicine, Bursa Uludağ University, 16059 Bursa, Turkey
5 shared publications - Nevin Hatipoğlu
Pediatric Infectious Diseases Unit, Bakirkoy Dr Sadi Konuk Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
5 shared publications - Sheldon L. Kaplan
Baylor College of Medicine
5 shared publications
Latest Publications
- 19 February 2024
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 18 (Suppl 1) , 1-30
Çocukluk Çağı Ateş Yönetimi Değerlendirmesi
- 19 February 2024
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 18 (Suppl 1) , 1-30
Çocukluk Çağı Ateş Yönetimi Değerlendirmesi
- 19 February 2024
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 18 (Suppl 1) , 1-31
Evaluation of Childhood Fever Management
- 19 February 2024
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 18 (Suppl 1) , 1-31
Evaluation of Childhood Fever Management
- Open Access
Pathogens in Pediatric Septic Arthritis: A Multi-Center Study in Turkiye (PEDSART Study)
Objectives: Septic arthritis (SA) is a serious bacterial infection that must be treated efficiently and timely. The large number of culture-negative cases makes local epidemiological data important. Accordingly, this study aimed to evaluate the etiology, clinical characteristics, and therapeutic approach of SA in children in Turkiye, emphasizing the role of real-time polymerase chain reaction (PCR) techniques in the diagnosis. Methods: In this multi-center, prospective study, children hospitalized due to SA between February 2018 and July 2020 in 23 hospitals in 14 cities in Turkiye were included. Clinical, demographic, laboratory, and radiological findings were assessed, and real-time PCR was performed using synovial fluid samples. Results: Seventy-five children aged between 3 and 204 months diagnosed with acute SA were enrolled. Joint pain was the main complaint at admission, and the most commonly involved joints were the knees in 58 patients (77.4%). The combination of synovial fluid culture and real-time PCR detected causative bacteria in 33 patients (44%). In 14 (18.7%) patients, the etiological agent was demonstrated using only PCR. The most commonly isolated etiologic agent was Staphylococcus aureus, which was detected in 22 (29.3%) patients, while Streptococcus pyogenes was found in 4 (5.3%) patients and Kingella kingae in 3 (4%) patients. Streptococcus pyogenes and Kingella kingae were detected using only PCR. Most patients (81.3%) received combination therapy with multiple agents, and the most commonly used combination was glycopeptides plus third-generation cephalosporin. Conclusions: Staphylococcus aureus is the main pathogen in pediatric SA, and with the use of advanced diagnostic approaches, such as real-time PCR, the chance of diagnosis increases, especially in cases due to Kingella kingae and Streptococcus pyogenes.
Open AccessPathogens in Pediatric Septic Arthritis: A Multi-Center Study in Turkiye (PEDSART Study)
Objectives: Septic arthritis (SA) is a serious bacterial infection that must be treated efficiently and timely. The large number of culture-negative cases makes local epidemiological data important. Accordingly, this study aimed to evaluate the etiology, clinical characteristics, and therapeutic approach of SA in children in Turkiye, emphasizing the role of real-time polymerase chain reaction (PCR) techniques in the diagnosis. Methods: In this multi-center, prospective study, children hospitalized due to SA between February 2018 and July 2020 in 23 hospitals in 14 cities in Turkiye were included. Clinical, demographic, laboratory, and radiological findings were assessed, and real-time PCR was performed using synovial fluid samples. Results: Seventy-five children aged between 3 and 204 months diagnosed with acute SA were enrolled. Joint pain was the main complaint at admission, and the most commonly involved joints were the knees in 58 patients (77.4%). The combination of synovial fluid culture and real-time PCR detected causative bacteria in 33 patients (44%). In 14 (18.7%) patients, the etiological agent was demonstrated using only PCR. The most commonly isolated etiologic agent was Staphylococcus aureus, which was detected in 22 (29.3%) patients, while Streptococcus pyogenes was found in 4 (5.3%) patients and Kingella kingae in 3 (4%) patients. Streptococcus pyogenes and Kingella kingae were detected using only PCR. Most patients (81.3%) received combination therapy with multiple agents, and the most commonly used combination was glycopeptides plus third-generation cephalosporin. Conclusions: Staphylococcus aureus is the main pathogen in pediatric SA, and with the use of advanced diagnostic approaches, such as real-time PCR, the chance of diagnosis increases, especially in cases due to Kingella kingae and Streptococcus pyogenes.
- 11 November 2023
- Published by Springer Nature
- p. 625-665
Nontuberculous Mycobacteria Infections in Children and Hearing Loss
- 11 November 2023
- Published by Springer Nature
- p. 625-665
Nontuberculous Mycobacteria Infections in Children and Hearing Loss
- 11 November 2023
- Published by Springer Nature
- p. 99-116
Congenital Toxoplasmosis and Hearing Loss
- 11 November 2023
- Published by Springer Nature
- p. 779-790
Viral Infections in Children and Hearing Loss: An Overview
- 11 November 2023
- Published by Springer Nature
- p. 779-790
Viral Infections in Children and Hearing Loss: An Overview
- 11 November 2023
- Published by Springer Nature
- p. 1065-1094
Antituberculous Agents for Pediatric Mycobacterial Diseases, and Hearing Loss
- 11 November 2023
- Published by Springer Nature
- p. 1065-1094
Antituberculous Agents for Pediatric Mycobacterial Diseases, and Hearing Loss
- 11 November 2023
- Published by Springer Nature
- p. 389-400
Bacterial Infections in Children and Hearing Loss: An Overview
- 11 November 2023
- Published by Springer Nature
- p. 389-400
Bacterial Infections in Children and Hearing Loss: An Overview
- 11 November 2023
- Published by Springer Nature
- p. 681-699
Bordetella Pertussis Infection and Hearing Loss
- 11 November 2023
- Published by Springer Nature
- p. 681-699
Bordetella Pertussis Infection and Hearing Loss